Theranostics 2022; 12(14):6159. doi:10.7150/thno.76869 This issue

Erratum

Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts: Erratum

Jianbin Xu1, Guolin Zhang1, Xin Luo1, Di Wang1, Wei Zhou1, Yan Zhang2, Wei Zhang1, Jiaxin Chen1, Qing Meng1, Engeng Chen1, Heng Chen3✉, Zhangfa Song1✉

1. Department of Colorectal Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310016, P.R. China.
2. State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, 300350, P.R. China.
3. Shenzhen Key Laboratory of Polymer Science and Technology, Guangdong Research Center for Interfacial Engineering of Functional Materials, College of Materials Science and Engineering, Shenzhen University, Shenzhen 518060, P.R. China.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Xu J, Zhang G, Luo X, Wang D, Zhou W, Zhang Y, Zhang W, Chen J, Meng Q, Chen E, Chen H, Song Z. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts: Erratum. Theranostics 2022; 12(14):6159. doi:10.7150/thno.76869. Available from https://www.thno.org/v12p6159.htm

File import instruction

Corrected-article in Theranostics, Volume 11, 2475